“Buffalo hump” in men with HIV-1 infection
暂无分享,去创建一个
Morris Schambelan | M. Schambelan | V. Tai | K. Mulligan | J. Lo | H. Algren | Kathleen Mulligan | Viva W Tai | Joan C Lo | Heather Algren
[1] M. Schambelan,et al. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[2] P. Björntorp,et al. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. , 1988, The Journal of clinical endocrinology and metabolism.
[3] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.
[4] J. Yanovski,et al. Glucocorticoid action and the clinical features of Cushing's syndrome. , 1994, Endocrinology and metabolism clinics of North America.
[5] B. Murphy,et al. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. , 1967, The Journal of clinical endocrinology and metabolism.
[6] P. Volberding,et al. The Medical Management of AIDS , 1988 .
[7] L. Crapo. Cushing's syndrome: a review of diagnostic tests. , 1979, Metabolism: clinical and experimental.
[8] P. Forsham,et al. A RAPID SCREENING TEST FOR CUSHING'S SYNDROME. , 1965, JAMA.
[9] R B Mazess,et al. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. , 1990, The American journal of clinical nutrition.
[10] W. Winkelmann,et al. DIAGNOSIS OF CUSHING'S SYNDROME , 1969 .
[11] Y. Matsuzawa,et al. Pathophysiology and Pathogenesis of Visceral Fat Obesity , 1993, Annals of the New York Academy of Sciences.
[12] J. Lennox,et al. Benign symmetric lipomatosis associated with protease inhibitors , 1997, The Lancet.
[13] K. Feingold,et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.
[14] P. Björntorp. The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[15] C. Grunfeld,et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. , 1993, The Journal of clinical endocrinology and metabolism.
[16] C. Sum,et al. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome , 1991, Steroids.
[17] G. Chrousos,et al. Hypercortisolism and Obesity , 1995, Annals of the New York Academy of Sciences.
[18] F. H. Tyler,et al. DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST. , 1965, Archives of internal medicine.
[19] P. Björntorp,et al. Steroid hormone receptors in human adipose tissues. , 1990, The Journal of clinical endocrinology and metabolism.
[20] P. Stewart,et al. Does central obesity reflect “Cushing's disease of the omentum”? , 1997, The Lancet.
[21] 藤岡 滋典. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity , 1987 .
[22] J. Doppman,et al. Biochemical and radiologic diagnosis of Cushing's syndrome. , 1994, Endocrinology and metabolism clinics of North America.